Remedium Capital Partners, LLC
Source: SEC Form 13F · as of Mar 2026Remedium Capital Partners, LLC holds 5 biotech & pharma companies tracked by BioSniper, totaling $274.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$274.5M
BioSniper AIPage context preserved
Prepared research question
What matters most for Oruka Therapeutics, Inc. (ORKA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ORKAOruka Therapeutics, Inc. | 1,565,661 | $76.8M |
| SYRESpyre Therapeutics, Inc. | 1,456,231 | $73.5M |
| DMRADamora Therapeutics, Inc. | 2,045,473 | $53.0M |
| APGEApogee Therapeutics, Inc. | 583,591 | $49.1M |
| JBIOJade Biosciences, Inc. | 1,577,750 | $22.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.